Randomized, Controlled Study of Adderall XR in ADHD
Abstract
The efficacy and safety of Adderall XR in the treatment of attention deficit/hyperactivity disorder and diurnal variation in responses were assessed by a multicenter, randomized, double-blind, parallel group, placebo-controlled trial at 47 sites, and reported from the Massachusetts General Hospital, Boston, MA.
DOI: https://doi.org/10.15844/pedneurbriefs-16-8-13 | Journal eISSN: 2166-6482
Language: English
Page range: 64 - 64
Published on: Aug 1, 2002
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2002 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.